期刊文献+

10-羟基喜树碱衍生物的合成及体外抑制肿瘤活性 被引量:3

Synthesis and antitumor activities of 10-hydroxy camptothecin derivatives
下载PDF
导出
摘要 目的 寻找高效低毒的喜树碱类抗肿瘤新药。方法 合成 7个喜树碱衍生物 (39) ,经1 HNMR ,IR ,MS分析确证了所合成化合物的结构 ,经MTT法筛选了对宫颈癌Hela、肝癌BEL 74 0 2、胃癌 790 1和大肠癌CCL 187瘤株的体外抑制肿瘤活性。结果  7个化合物分别对前三种瘤株有效 ,其中化合物 4对前三种瘤株均有较好的体外抑制肿瘤细胞活性 ,尤其对宫颈癌Hela细胞的抑制活性大于 10 羟基喜树碱。 Aim To find new anticancer drug based on the structure of 10-hydroxy camptothecin. Methods Seven camptothecin derivatives (3-9) were synthesized and the antitumor activities of these derivatives were evaluated. Results Structures of seven new compounds were determined by 1HNMR, IR, MS. Seven compounds showed inhibitory effects on Hela, BEL-7402, 7901 cell lines in vitro. Especially, compound 4 showed high bioactivities to all of the tumor cells in vitro, its anticancer activity against human cervical carcinoma Hela was much higher than that of 10-hydroxy camptothecin. Conclusion Some compounds are worth further studying.
出处 《药学学报》 CAS CSCD 北大核心 2004年第7期521-524,共4页 Acta Pharmaceutica Sinica
基金 国家自然科学基金资助项目 ( 3 0 0 70 610 )
关键词 10-羟基喜树碱 衍生物 抗癌活性 hydroxy camptothecin derivatives antitumor activity
  • 相关文献

参考文献12

  • 1Wall ME, Wani MC, Cook CE, et al. Plant antitumor agents. The isolation and structure of camptothecin, a novel alkaloidal leukemia and tumor inhibitor from Camptotheca acuminata [J] . J Am Chem Soc , 1966, 88(16) :3888 -3890.
  • 2Wani MC, Nicholas AW, Wall ME. Plant antitumor agents. 23. Synthesis and antileukemic activity of camptothecin analogues [J]. J Med Chem, 1986, 29(11) :2358 - 2363.
  • 3S1ichenmyer WJ, Von Hoff DD. New natural products in cancer chemotherapy [J]. J Clin Pharmacol, 1990, 30(9) :770-788.
  • 4Hsiang YH, Hertzberg R, Hecht S, et al. Camptothecin induces protein linked breaks via mammalian DNA topoisomerase I [J]. J Biol Chem, 1985, 260:14873-14878.
  • 5Shin CG, Snapka RM. Patterns of strongly proteinassociated simian virus 40 DNA replication intermediates resulting from exposures to specific topoisomerase poisons [J]. Biochemistry, 1990, 29 (49): 10934 - 10939.
  • 6Robinson C, Robinson K, Castaner J. 9-Aminocamptothecin [J]. Drugs Future, 1996, 21:881 -889.
  • 7Eckhardt SG, Baker SD, Eckhardt JR, et al. Phase Ⅰ and pharmacokinetics study of G/147211, a water-soluble camptothecin analogue, administered for five consecutive days every three weeks [J]. Clin Cancer Res, 1998, 4:595 - 604.
  • 8Kumazawa E, Jimbo T, Ochi Y, et al. Potent and broad antititumor effects of DX-8951f, a water-soluble camptothecin derivative, against various human tumors xenografted in nude mice [J]. Cancer Chemother Pharmacol, 1998,42:210 - 220.
  • 9Sabrina Dallavalle, Anna Ferrari, Barbara Biasotti, et al. Novel 7-oxyiminomethyl derivatives of camptothecin with potent in vitro and in vivo antitumor activity [J]. J Med Chem, 2001,44:3264-3274.
  • 10OsherhoffN.Biochemical basis for the interactions of type Ⅰ and type Ⅱ topoisomerases with DNA [J].Pharmacol Ther,1989,41(2):223-241.

同被引文献22

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部